The historic rise of Viagra has firmly established as a example of pharmaceutical success, however its legacy within the broader sector now triggers questions about long-term returns . Copycat versions are diminishing patent protection , causing worries that betting on companies heavily reliant to Viagra's once-dominant position could be a dangerou